Colitis, Microscopic: Clinical Trials

6 trials for Colitis, Microscopic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 21Completed 1

Follow Colitis, Microscopic: new trials by email Literature Review of Colitis, Microscopic trials Research Report on Colitis, Microscopic

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
Budesonide, Mesalamine, Placebo - Lymphocytic Colitis
Phase 3CompletedDr. Falk Pharma GmbH572010-05-012017-07-26
SOIBD Collagenous Colitis Maintenance Study
Budesonide, Placebo - Induction and Maintaining Remission of Collagenous Colitis
Phase 3CompletedDr. Falk Pharma GmbH922008-04-012016-01-21
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
Budesonide, Mesalazine, Placebo - Collagenous Colitis
Phase 3CompletedDr. Falk Pharma GmbH922007-03-012014-05-19
Trial of Mesalamine for the Treatment of Active Microscopic Colitis
Mesalamine - Microscopic Colitis, Diarrhea
Phase 2 / Phase 3CompletedMayo Clinic702007-02-012011-05-24
Budesonide for Maintenance Treatment of Collagenous Colitis
Budesonide - Collagenous Colitis
Phase 3CompletedTechnische Universität Dresden752004-07-012010-03-30
Budesonide Treatment for Lymphocytic Colitis
Budesonide - Microscopic Colitis
Phase 3CompletedTechnische Universität Dresden402002-01-012010-03-30

Narrower conditions

Colitis, Collagenous (3)  ·  Colitis, Lymphocytic (2)  ·  Diarrhea (1)

Broader conditions

Colitis (6)  ·  Colonic Diseases (6)  ·  Digestive System Diseases (6)  ·  Gastroenteritis (6)  ·  Gastrointestinal Diseases (6)  ·  Intestinal Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Budesonide (5)  ·  Mesalamine (3)

Sponsors

Dr. Falk Pharma GmbH (3)  ·  Technische Universität Dresden (2)  ·  Mayo Clinic (1)

Countries

Germany (5)  ·  Sweden (1)  ·  United States (1)

Top investigators

Stephan Miehlke, Prof. (2)  ·  Stephan Miehlke, Professor (2)

Results publications

PMID 24440672, PMID 25425655, PMID 30195447

NIH funding

2008 (1)